OncoEase™ Genistein Capsule，Inhibiting Tumor Growth and Metastasis;Suitable for Patients with Various Types of Tumors.Unique Chinese Ancient Plant Extract, Natural without Side Effects

 OncoEase™ Genistein Capsulese💊

OncoEase™ Genistein Capsules are produced using advanced technology, derived from natural Isoflavone compounds extracted from unique Chinese plants—Sophora Japonica. The primary active ingredient is Genistein, which through pharmacological experiments and clinical trials has been proven to inhibit the growth and metastasis of tumors.

Genistein:

1. Specific tyrosine protein kinase inhibitor and topoisomerase II inhibitor.

2. Well-defined structure and mechanism, strong anticancer activity.

3. Inhibits cancer cell growth, invasion, and metastasis through multiple pathways.

4. Pure natural isoflavone compound, controls oncogenes, no toxic side effects.

5. Prevents tumor spread and metastasis, prolongs patient survival.

6. Synergistic effect when used with chemotherapy drugs, more effective against metastasis.

7. Broad anticancer and cancer-preventive activities, suitable for all stages of various malignant tumors.

• Product Name 
  • OncoEase™ Genistein Capsules
• Active Ingredients and Content
  • Each 100 mg of capsules contains 14-18 mg of Genistein.
• Function
  • Inhibits tumor growth and metastasis.
• Indications
  • Indicated for patients with various types of tumors to inhibit tumor growth and metastasis.
• Contraindications
  • Not suitable for Pregnant women and infants.
• Directions and Dosage
  • One treatment cycle lasts three months, with three capsules per time and taken three times daily after meals, accompanied by water.
• Specification
  • 250 mg per capsule, 12 capsules per blister pack, 3 blister packs per box.

• Shelf Life
  • 18 months.
• Storage
  • Store in a cool, dry place.
• Origin
  •  China
• Quality Standard
  • Q/RL 0001S
• Manufacturing License Number
  •  SC11413010900432 
• Approval Number 
  • Approved by the Ministry of Health of the People's Republic of China: No(1999)0387
• Research and Development Institution
  • Institute of Materia Medica, CAMS & PUMC.
• Manufacturer 
  • Jointly manufactured by North China Pharmaceutical Group Co., Ltd.and Rongli Pharmaceutical Research Institute.